GTAM2 Marker Antibody (4i309): sc-71194

GTAM2 Marker Antibody (4i309) is a mouse monoclonal IgG1 antibody that detects the GTAM2 Marker protein of human origin by western blotting (WB), immunofluorescence (IF), and immunohistochemistry. Anti-GTAM2 Marker antibody (4i309) is available as the non-conjugated format. GTAM2, or gastrointestinal tumor associated marker 2, plays a crucial role in identifying gastric carcinoma, a cancer that can arise in any part of the stomach and metastasize to other organs such as the esophagus and small intestine. GTAM2 expression is particularly significant as GTAM2 localizes in the luminal and apical cytoplasm of pancreatic cancer cells, as well as in lung, colon, and gastric carcinomas, making GTAM2 a valuable marker for malignancy. GTAM2 presence in tumor membranes highlights GTAM2′s potential as a diagnostic tool, aiding in early carcinoma detection and differentiation between benign and malignant conditions. Given the challenges in diagnosing gastric carcinoma, GTAM2 specificity for cancerous tissues underscores GTAM2′s importance in both research and clinical settings, providing insights that can lead to improved treatment strategies.